DK1276495T3 - Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme - Google Patents

Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme

Info

Publication number
DK1276495T3
DK1276495T3 DK01943250T DK01943250T DK1276495T3 DK 1276495 T3 DK1276495 T3 DK 1276495T3 DK 01943250 T DK01943250 T DK 01943250T DK 01943250 T DK01943250 T DK 01943250T DK 1276495 T3 DK1276495 T3 DK 1276495T3
Authority
DK
Denmark
Prior art keywords
early treatment
pulmonary diseases
acute pulmonary
surfactant preparations
lung surfactant
Prior art date
Application number
DK01943250T
Other languages
Danish (da)
English (en)
Inventor
Christoph Karl
Dietrich Haefner
Frank Rathgeb
Peter Schaffer
Wilhelm Wurst
Andreas Keller
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK1276495T3 publication Critical patent/DK1276495T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01943250T 2000-04-12 2001-04-12 Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme DK1276495T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00107858 2000-04-12

Publications (1)

Publication Number Publication Date
DK1276495T3 true DK1276495T3 (da) 2006-08-14

Family

ID=8168443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01943250T DK1276495T3 (da) 2000-04-12 2001-04-12 Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme

Country Status (12)

Country Link
US (1) US20030158087A1 (fr)
EP (1) EP1276495B1 (fr)
JP (1) JP2003530356A (fr)
AT (1) ATE323505T1 (fr)
AU (1) AU2001265876A1 (fr)
CA (1) CA2405811C (fr)
DE (1) DE60118898T2 (fr)
DK (1) DK1276495T3 (fr)
ES (1) ES2262656T3 (fr)
PT (1) PT1276495E (fr)
SI (1) SI1276495T1 (fr)
WO (1) WO2001076619A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
WO2003053455A1 (fr) 2001-12-12 2003-07-03 Penn State Research Foundation Surfactants destines au traitement de la fibrose pulmonaire
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
ATE547104T1 (de) * 2003-06-16 2012-03-15 Nycomed Gmbh Zusammensetzung enthaltend einen lungensurfactant und sildenafil zur behandlung von lungenerkrankungen
US8236750B2 (en) 2004-08-06 2012-08-07 Nycomed Gmbh Composition comprising a pulmonary surfactant and a TNF-derived peptide
RU2577698C2 (ru) * 2009-03-26 2016-03-20 Пулмэтрикс, Инк. Сухие порошкообразные составы и способы лечения легочных заболеваний
EP2407150A1 (fr) * 2010-07-16 2012-01-18 Justus-Liebig-Universität Gießen Nano- et microparticules polymèriques pour maintenir la tension de surface dans les poumons et pour la protection de les tensioactifs pulmonaire

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013619A (en) * 1988-01-06 2000-01-11 The Scripps Research Institute Pulmonary surfactants and therapeutic uses, including pulmonary lavage
GB9021080D0 (en) * 1990-09-26 1990-11-07 Univ Western Ontario Lipid extract surfactant and method of producing same
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
DE4434629C1 (de) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
WO1998052588A1 (fr) * 1997-05-21 1998-11-26 Medion Research Laboratories Inc. Agents therapeutiques adaptes a des affections respiratoires
DE19827907C2 (de) * 1998-06-23 2003-05-15 Altana Pharma Ag Neue pharmazeutische Zusammensetzungen zur Behandlung von IRDS und ARDS
WO2000027360A1 (fr) * 1998-11-10 2000-05-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Appareil de traitement contenant des compositions a base de surfactants pulmonaires
US7135452B1 (en) * 1999-01-19 2006-11-14 Altana Pharma Ag Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases

Also Published As

Publication number Publication date
WO2001076619A1 (fr) 2001-10-18
JP2003530356A (ja) 2003-10-14
US20030158087A1 (en) 2003-08-21
AU2001265876A1 (en) 2001-10-23
SI1276495T1 (sl) 2006-10-31
ATE323505T1 (de) 2006-05-15
DE60118898T2 (de) 2006-11-16
CA2405811A1 (fr) 2001-10-18
PT1276495E (pt) 2006-08-31
CA2405811C (fr) 2011-09-27
EP1276495B1 (fr) 2006-04-19
EP1276495A1 (fr) 2003-01-22
DE60118898D1 (de) 2006-05-24
ES2262656T3 (es) 2006-12-01

Similar Documents

Publication Publication Date Title
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
NO20030845D0 (no) Utvalgte fusjonerte pyrrolokarbazoler
ATE424413T1 (de) Analoge des glucagon-ähnlichen peptids-1
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
DE60009511D1 (de) Nematizide trifluorbutene
NO2012018I1 (no) Canakinumab eller direkte ekvivalenter derav
BR0215405A (pt) Composições e processos de uso de collajolie
DE60126838D1 (de) Amidoacetonitrile zur Bekämpfung von Endoparasiten
ATE330017T1 (de) Kallikrein gen
RS50071B (sr) Novi oblik soli pantoprazola
ATE308324T1 (de) Zolpidem hemitartrat
ATE363531T1 (de) Claudin polypeptide
CY1106746T1 (el) Χρηση του irbesartan για την προληψη ή τη θεραπεια της πνευμονικης υπερτασης
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
DK1276495T3 (da) Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1173194T3 (da) Rekombinant SP-A til behandlingen eller forebyggelsen af lungeinfektion og -inflammation
DE60134885D1 (de) Antiangiogene polypeptide
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
ATE414154T1 (de) Moraxella (branhamella) catarrhalis antigene
DE60230984D1 (de) Moraxella (branhamella) catarrhalis antigene
SE0101762D0 (sv) New use
DE60229871D1 (de) Moraxella (branhamella) catarrhalis polypeptide
IT1318363B1 (it) Procedimento per la lavorazione di piastrelle ceramiche.
ITLU20010004U1 (it) Calzature con utilizzo di soffietti fissi o inseribili